Infliximab Indications & Contraindications: Acute Sinusitis Is NOT an Indication
FDA-Approved Indications for Infliximab (Remicade®)
- Rheumatoid Arthritis (with methotrexate)
- Crohn's Disease (moderate-severe, fistulizing)
- Ulcerative Colitis (moderate-severe)
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Plaque Psoriasis (chronic severe)
- Pediatric Crohn's / UC (age ≥6)
Question Analysis
The question lists four options; Acute Sinusitis (D) is NOT an indication.
Mechanism
Infliximab = chimeric monoclonal antibody against TNF-α. Blocks soluble & transmembrane TNF-α → reduces inflammatory cascade in autoimmune diseases.
Key Safety Considerations
- TB screening (latent TB activation risk)
- Hepatitis B reactivation
- Infection risk (opportunistic, bacterial, fungal)
- Malignancy risk (lymphoma, skin cancer)
- Heart failure exacerbation
- Demyelinating disorders
- Pregnancy category B (crosses placenta 2nd/3rd tri)
Administration
- IV infusion over 2+ hours
- Premedication (antihistamine, acetaminophen, ± steroid)
- Dosing: weight-based, condition-specific intervals
Illness - Related Articles
- Understanding the Multifactorial Model of Disease: Causes & Diagnosis
- Effective Maggot Removal: Prevention & Solutions
- Liver Health & Antibiotics: Can You Support Your Liver During Treatment?
- Green Amethyst: Properties, Meaning & Healing Benefits
- Overcome Mouse Fear: Understanding and Treatment of Suriphobia
- Night Sweats: Causes, Symptoms & When to See a Doctor
- Effective Home Remedies for Sore Throats: Natural Relief
